Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ophthalmology
  Free Subscription

Articles published in
J Ocul Pharmacol Ther
    September 2025
  1. DMUCHOWSKA DA, Godzien J, Mojsak P, Godlewski A, et al
    Comment on: Changes in Aqueous Humor Cytokines and Metabolomics in Contralateral Eye After Unilateral Cataract Surgery.
    J Ocul Pharmacol Ther. 2025 Sep 19. doi: 10.1177/10807683251380991.
    >> Share

  2. RASSI TNO, Amaral DC, Mund E, Pimentel ALM, et al
    Assessing Long-Term Feasibility and Efficacy of Treatments for Retinal Vein Occlusion Macular Edema: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials.
    J Ocul Pharmacol Ther. 2025 Sep 18. doi: 10.1177/10807683251380974.
    >> Share

  3. ZENG F, He H, Huang S, Luo Y, et al
    Brimonidine Topical Eye Drops and Intravitreal Administration Inhibit Form-Deprivation Myopia in Guinea Pigs: Ocular Pharmacokinetics and Irritation.
    J Ocul Pharmacol Ther. 2025 Sep 18. doi: 10.1177/10807683251376438.
    >> Share

  4. LEE H, Sharma A, Woo SJ
    Clinical Trials of Aflibercept Biosimilars: A Review.
    J Ocul Pharmacol Ther. 2025;41:363-369.
    >> Share

  5. KHOLZODA S, Ozkan G, Dericioglu V, Akkaya Turhan S, et al
    Topical Cyclosporine and Steroid Treatments: A Comparative Approach to Membranous Punctal Stenosis.
    J Ocul Pharmacol Ther. 2025;41:387-396.
    >> Share

    August 2025
  6. YILDIRIM H, Balbaba M, Canleblebici M, Dal A, et al
    Effect of Dasatinib on Oxidative Stress and Neovascularization in Experimental Corneal Neovascularization.
    J Ocul Pharmacol Ther. 2025 Aug 21. doi: 10.1177/10807683251370551.
    >> Share

  7. FEKI O, Zhioua-Braham I, Haddar S, Arfaoui A, et al
    The Endocannabinoid System: Role in Ocular Physiology and Therapeutic Potential in Eye Diseases: A Narrative Review.
    J Ocul Pharmacol Ther. 2025 Aug 21. doi: 10.1177/10807683251368650.
    >> Share

  8. SHEN M, Xu B
    Rosmarinic Acid Mitigates Lipopolysaccharide-Induced Inflammation and Oxidative Stress in Human Corneal Epithelial Cells as an In Vitro Keratitis Cell Model.
    J Ocul Pharmacol Ther. 2025 Aug 15. doi: 10.1177/10807683251366780.
    >> Share

  9. NORK TM, Katz AW, Rasmussen CA, Kim CBY, et al
    Custom-Made Injector for Suprachoroidal Ocular Delivery: Effect of Intraocular Pressure, Volume, and Location on the Distribution of Aqueous Solutions in Rabbits.
    J Ocul Pharmacol Ther. 2025 Aug 8. doi: 10.1177/10807683251366799.
    >> Share

  10. LEI J, Zeng L, Gao X, Wang D, et al
    Comparison of Topical Gatifloxacin and Levofloxacin at Different Durations in Eliminating Conjunctival Bacterial Flora.
    J Ocul Pharmacol Ther. 2025 Aug 6. doi: 10.1177/10807683251366114.
    >> Share

  11. XIA R, Lin L, Liu Z, Chen W, et al
    Nonsurgical Therapies for Preventing Corneal Scarring: A Systematic Review of the Past Decade.
    J Ocul Pharmacol Ther. 2025 Aug 6. doi: 10.1177/10807683251361725.
    >> Share

  12. KHAN H, Aftab OM, Billah MS, Khouri AS, et al
    Beyond the Prostate: A Visionary Study on Ocular Impacts of Benign Prostatic Hyperplasia Drugs.
    J Ocul Pharmacol Ther. 2025 Aug 6. doi: 10.1089/jop.2025.0030.
    >> Share

  13. WANG Z, Li G, Lu H, Wang J, et al
    The Efficacy and Safety of Tumor Necrosis Factor alpha Inhibitors in the Treatment of Noninfectious Uveitis: A Systematic Review and Meta-Analysis.
    J Ocul Pharmacol Ther. 2025 Aug 5. doi: 10.1177/10807683251363436.
    >> Share

  14. MONTMEAT D, Thouvenin A, Rasamison R, Boudy V, et al
    Physicochemical Properties and Rheological Behavior of Artificial Tears for Dry Eye Syndrome.
    J Ocul Pharmacol Ther. 2025 Aug 5. doi: 10.1177/10807683251364169.
    >> Share

  15. CHOUDHRY HS, Pei M, Mothy D, Scarfuto J, et al
    Real-World Safety Profile of Cenegermin Per FDA Adverse Event Reporting System.
    J Ocul Pharmacol Ther. 2025;41:339-346.
    >> Share

    July 2025
  16. ROJAS R, Hinkle DM
    Infectious, Immune-Mediated, and Vaccine-Associated Ocular Adverse Events.
    J Ocul Pharmacol Ther. 2025 Jul 30. doi: 10.1177/10807683251363420.
    >> Share

  17. HERBOTS H, Van Os L, Aerts W, Tassignon MJ, et al
    Evaluation of Systemic Exposure to Intracameral Tropicamide 0.02%, Phenylephrine 0.31%, and Lidocaine 1% in Pediatric Cataract Surgery.
    J Ocul Pharmacol Ther. 2025 Jul 18. doi: 10.1177/10807683251359451.
    >> Share

  18. ZHOU J, Wang D, Li GC, Huang Q, et al
    GCN5-TFEB Pathway Regulates Inflammation by Tuning Autophagic Degradation of Retinoic Acid-Induced Gene-I in Human Conjunctival Epithelial Cells.
    J Ocul Pharmacol Ther. 2025 Jul 9. doi: 10.1089/jop.2025.0029.
    >> Share

    June 2025
  19. SUN N, Hu X, Wang J, Yao T, et al
    Minichromosome Maintenance Complex Genes Are Candidate Biomarkers of Retinal Degeneration.
    J Ocul Pharmacol Ther. 2025 Jun 27. doi: 10.1089/jop.2025.0047.
    >> Share

  20. WANG Q, Peng Y, Wang S, Xu J, et al
    Exploring the Efficacy of AZD6738 in Corneal Neovascularization: Autophagy Enhancement and Angiogenesis Inhibition.
    J Ocul Pharmacol Ther. 2025 Jun 27. doi: 10.1089/jop.2024.0162.
    >> Share

  21. SRIKAJORN C, Tiyaboonchai W, Srinivas SP, Thongsuk W, et al
    Mucoadhesive Silk Fibroin Nanoparticles for Drug Delivery to the Ocular Surface.
    J Ocul Pharmacol Ther. 2025 Jun 24. doi: 10.1089/jop.2024.0180.
    >> Share

  22. KROSSER S, Grillenberger R, Eickhoff K, Korward J, et al
    Ocular Pharmacokinetics and Biodistribution of Perfluorohexyloctane after Topical Administration to Rabbits.
    J Ocul Pharmacol Ther. 2025 Jun 19. doi: 10.1089/jop.2025.0056.
    >> Share

  23. OZGUR A, Ozmen MC, Yalinbas Yeter D, Inan MA, et al
    Antineovascular Effects of Coenzyme Q10 and Vitamin E Combination in Corneal Neovascularization: A Pilot Study.
    J Ocul Pharmacol Ther. 2025 Jun 11. doi: 10.1089/jop.2025.0068.
    >> Share

  24. CHU G, Wang J, Wang Z, Cai X, et al
    Autologous Serum from Sjogren's Syndrome Patients Mitigates Ferroptosis in Hyperosmolarity-Induced Corneal Epitheliopathy.
    J Ocul Pharmacol Ther. 2025 Jun 11. doi: 10.1089/jop.2025.0025.
    >> Share

  25. PADMANABHAN NAIR A, Machiraju P, Tejwani S, Dinakaran S, et al
    Lower Levels of Endogenous Intraocular Interferon Beta in Patients with Primary Glaucoma.
    J Ocul Pharmacol Ther. 2025 Jun 9. doi: 10.1089/jop.2025.0085.
    >> Share

  26. SUN CC, Pan LY, Chen NN, Kuo YK, et al
    Risk and Protective Factors for Ocular Surface Disease in Patients with Type 2 Diabetic Mellitus: A Retrospective Cohort Study.
    J Ocul Pharmacol Ther. 2025 Jun 9. doi: 10.1089/jop.2024.0175.
    >> Share

  27. SADRI E, Verachtert A, Parkhurst GD, Echegoyen J, et al
    Durability of Treatment with a Thermomechanical Device in Meibomian Gland Dysfunction: An Observational Extension Study.
    J Ocul Pharmacol Ther. 2025;41:237-243.
    >> Share

  28. DOLAN K
    Rosalind Franklin Society Proudly Announces the 2024 Award Recipient for Journal of Ocular Pharmacology and Therapeutics.
    J Ocul Pharmacol Ther. 2025;41:229.
    >> Share

    May 2025
  29. ROY A, Kompella UB
    Rose Bengal-Assisted Photodynamic Antimicrobial Therapy for Keratitis.
    J Ocul Pharmacol Ther. 2025 May 29. doi: 10.1089/jop.2025.0010.
    >> Share

  30. LACAU S, Marin A, Bitrian E
    Steroid-Induced Ocular Hypertension in Children: A Review on Risk Factors.
    J Ocul Pharmacol Ther. 2025 May 13. doi: 10.1089/jop.2025.0024.
    >> Share

  31. AFTAB OM, Khan H, Aftab B, Haque W, et al
    Corneal Complications: Drug-Induced Deposits and Food and Drug Administration Adverse Event Reporting System Data Insights-A Retrospective Study.
    J Ocul Pharmacol Ther. 2025 May 5. doi: 10.1089/jop.2024.0178.
    >> Share

  32. SHARMA A, Sharma PK, Kompella UB
    Lotilaner for Demodex Blepharitis: The Journey from Veterinary Use to Human Medicine.
    J Ocul Pharmacol Ther. 2025;41:173-186.
    >> Share

  33. NAVARRO-NARANJO PI, Chacon-Aponte A, Artunduaga-Rodriguez G
    Clinical Results of the Use of a Combined Solution of 0.5% Carboxymethylcellulose, 0.9% Glycerin, and 3% Trehalose for the Treatment of Dry Eye Disease.
    J Ocul Pharmacol Ther. 2025;41:210-216.
    >> Share

    April 2025
  34. FAHMY A, Ahmed M, Pflugfelder S, Serikbaeva A, et al
    Comparative Efficacy of Current Topical Treatments for Dry Eye Disease: A Review of Pivotal Clinical Trials Evaluating Corneal Staining Outcomes.
    J Ocul Pharmacol Ther. 2025 Apr 28. doi: 10.1089/jop.2024.0192.
    >> Share

  35. LIU J, Jiang E, Kim H, Moon J, et al
    Beneficial Effect of Rebamipide Eye Drops on Blue Light-Induced Oxidative Damage in the Ocular Surface.
    J Ocul Pharmacol Ther. 2025 Apr 28. doi: 10.1089/jop.2024.0208.
    >> Share

  36. SANCHEZ-TOCINO H, Villanueva Gomez A, Saldana Burgos R, Hata Viveiros MM, et al
    Myopia Progression Study Comparing Low-Dose (0.01%) Atropine Eye Drops with a Control Group.
    J Ocul Pharmacol Ther. 2025 Apr 18. doi: 10.1089/jop.2024.0202.
    >> Share

  37. QUIRKE M, Lamoureux F, Arnoult C, Gress G, et al
    Tacrolimus 0.1% Ophthalmic Suspension: Corneal and Intraocular Penetration Study.
    J Ocul Pharmacol Ther. 2025 Apr 18. doi: 10.1089/jop.2024.0165.
    >> Share

  38. PETTY RM, Rangan RS, Curry S, Brooks CD, et al
    Biodistribution of Reconstituted High-Density Lipoprotein Nanoparticles for Targeted Delivery to Retinal Ganglion Cells.
    J Ocul Pharmacol Ther. 2025 Apr 18. doi: 10.1089/jop.2024.0191.
    >> Share

  39. DUTRA BAL, Wilson SE
    Topical Losartan in the Management of Corneal Scarring Fibrosis: Update on Dosage, Efficacy, and Potential Epithelial Toxicity.
    J Ocul Pharmacol Ther. 2025 Apr 16. doi: 10.1089/jop.2024.0200.
    >> Share

  40. REITINGER JC, Reed DM, Peres C, Fan S, et al
    Understanding Individual Intraocular Pressure Response to Treatment with Latanoprost and Timolol.
    J Ocul Pharmacol Ther. 2025 Apr 14. doi: 10.1089/jop.2024.0112.
    >> Share

  41. JIN H, Yoon HJ, Jiang E, Liu J, et al
    Therapeutic Effects of Human Placental Extracts Eye Drops in Experimental Dry Eye and Alkali Burn.
    J Ocul Pharmacol Ther. 2025;41:141-149.
    >> Share

    March 2025
  42. KISHI A, Bryant AD, Reed DM, Toris CB, et al
    Letter to the Editor: Effect of Aqueous Tears on Topical Fluorescein Tracer Emission Signal from Cornea and Anterior Chamber.
    J Ocul Pharmacol Ther. 2025 Mar 10. doi: 10.1089/jop.2024.0143.
    >> Share

  43. PUTRI LR, Edwar L
    Corticosteroid as Treatment in Infective Conjunctivitis: A Systematic Literature Review and Meta-Analysis.
    J Ocul Pharmacol Ther. 2025 Mar 10. doi: 10.1089/jop.2024.0110.
    >> Share

  44. AFTAB OM, Khan H, Bargoud A, Khouri AS, et al
    Are Alpha-2 Adrenergic Agonists Being Used in Infants?
    J Ocul Pharmacol Ther. 2025;41:75-78.
    >> Share

    February 2025
  45. ROUTH BL, Tripathi R, Giuliano EA, Lankau BR, et al
    Effect of Chemical Injury on Autophagy in Canine Corneal Stromal Fibroblasts.
    J Ocul Pharmacol Ther. 2025 Feb 17. doi: 10.1089/jop.2024.0211.
    >> Share

  46. ALEKSANDER-IVANOV Y, Amaral DC, Cheidde L, Lima GN, et al
    Safety and Efficacy of 0.1% Cyclosporine Solutions in Dry Eye Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    J Ocul Pharmacol Ther. 2025 Feb 10. doi: 10.1089/jop.2024.0169.
    >> Share

  47. VOUGHT R, Vought V, Crane AB, Khouri AS, et al
    Medicare Part D Glaucoma Drug Prescribing Patterns by Ophthalmologists from 2018 to 2022.
    J Ocul Pharmacol Ther. 2025 Feb 5. doi: 10.1089/jop.2024.0196.
    >> Share

  48. HONG S, Woo M, Eom Y, Kim HK, et al
    A Multicenter, Randomized, Clinical Trial Assessing the Effect of rTG-Omega 3 Supplementation on Meibomian Gland Dysfunction Patients after Cataract Surgery rTG-Omega 3 for Meibomian Gland Dysfunction.
    J Ocul Pharmacol Ther. 2025 Feb 5. doi: 10.1089/jop.2024.0160.
    >> Share

  49. SADIKAN MZ, Lambuk L, Reshidan NH, Abdul Ghani NA, et al
    Age-Related Macular Degeneration Pathophysiology and Therapeutic Potential of Tocotrienols: An Update.
    J Ocul Pharmacol Ther. 2025 Feb 3. doi: 10.1089/jop.2024.0123.
    >> Share

    January 2025
  50. COSKUN A, Senturk F, Turan E
    Enhanced Transepithelial Riboflavin Delivery Across the Cornea Using Magnetic Nanocarriers.
    J Ocul Pharmacol Ther. 2025 Jan 30. doi: 10.1089/jop.2024.0183.
    >> Share

  51. SARKAR T, Gogoi NR, Jana BK, Mazumder B, et al
    Formulation Advances in Posterior Segment Ocular Drug Delivery.
    J Ocul Pharmacol Ther. 2025 Jan 23. doi: 10.1089/jop.2024.0153.
    >> Share

  52. CRUZ MRB, Amaral DC, Goncalves OR, Cyrino LG, et al
    Chlorhexidine Compared with Povidone-Iodine in Intravitreal Injection: A Systematic Review and Meta-Analysis.
    J Ocul Pharmacol Ther. 2025 Jan 21. doi: 10.1089/jop.2024.0141.
    >> Share

  53. GRESS G, Lamoureux F, Bourgain J, Ganem A, et al
    Selective Tissue Penetration of the Corneal Layers of Cyclosporin 2% Associated with Miglyol in Rabbits.
    J Ocul Pharmacol Ther. 2025 Jan 20. doi: 10.1089/jop.2024.0087.
    >> Share

  54. SADIKAN MZ, Lambuk L, Reshidan N, Ahmad Hairi H, et al
    Molecular Mechanisms of Vitamin E in Ocular Neurodegenerative Disorders: An Update on the Emerging Evidence and Therapeutic Implications.
    J Ocul Pharmacol Ther. 2025 Jan 8. doi: 10.1089/jop.2024.0125.
    >> Share

  55. HOARAU G, Best AL, Zina-Meziou S, Benali-Abdallah M, et al
    Effects of Intense Pulsed Light on Presumed Neuropathic Pain Associated with Meibomian Gland Dysfunction: A Before-After Study.
    J Ocul Pharmacol Ther. 2025;41:24-32.
    >> Share

    December 2024
  56. IRFAN AMSM, Geoffrey S, Htet H, Krishnappa P, et al
    N-Methyl-d-Aspartate-Induced Excitotoxicity and Its Impact on the Renin-Angiotensin System in Retinal Tissue.
    J Ocul Pharmacol Ther. 2024 Dec 13. doi: 10.1089/jop.2024.0131.
    >> Share

  57. KOVALIS N, Graffi S, Safuri S, Shapira Y, et al
    Duration of Bare Sclera Pterygium Surgery Combined with Mitomycin C with and Without Tranexamic Acid: A Randomized Double-Blind Controlled Trial.
    J Ocul Pharmacol Ther. 2024;40:675-679.
    >> Share

  58. YAN YL, Chang JY, Ling XR, Xue CY, et al
    Effects of Rebamipide for Dry Eye on Optical Quality and Efficacy: A Systematic Review and Meta-Analysis.
    J Ocul Pharmacol Ther. 2024;40:629-637.
    >> Share

  59. WANG N, Yuan K, Yang S, Jin X, et al
    13-cis Retinoic Acid-Mediated Modulation of Human Meibomian Gland Epithelial Cells Development: Implications for In Vitro Modeling of Meibomian Gland Dysfunction.
    J Ocul Pharmacol Ther. 2024;40:659-667.
    >> Share

  60. BHUJBAL S, Rupenthal ID, Steven P, Agarwal P, et al
    Inflammation in Dry Eye Disease-Pathogenesis, Preclinical Animal Models, and Treatments.
    J Ocul Pharmacol Ther. 2024;40:638-658.
    >> Share

  61. SEETHARAMAN ATM, Owens CE, Gangaraju R
    Cysteinyl Leukotriene Receptor Antagonism by Montelukast to Treat Visual Deficits.
    J Ocul Pharmacol Ther. 2024;40:617-628.
    >> Share

    November 2024
  62. ERB C, Topouzis F, Jayaram H, Allan F, et al
    Preclinical and Clinical Pharmacokinetics of a New Preservative-Free Bimatoprost 0.01% Ophthalmic Gel to Treat Glaucoma and Ocular Hypertension.
    J Ocul Pharmacol Ther. 2024 Nov 7. doi: 10.1089/jop.2024.0092.
    >> Share

  63. ROWE-RENDLEMAN CL
    Regulatory Requirements of Biosimilars: Drug Development in Ophthalmology, Part 1.
    J Ocul Pharmacol Ther. 2024 Nov 4. doi: 10.1089/jop.2024.0151.
    >> Share

  64. NGUYEN A, Naidoo KK, Ajouz L, Xu X, et al
    Changes in Human Meibum Lipid Composition Related to the Presence and Severity of Meibomian Gland Dysfunction.
    J Ocul Pharmacol Ther. 2024;40:562-570.
    >> Share

    October 2024
  65. HWANG JS, Song HB, Lee G, Jeong S, et al
    Extracellular Vesicles Derived from Adipose-Derived Mesenchymal Stem Cells Alleviate Apoptosis and Oxidative Stress of Retinal Pigment Epithelial Cells Through Activation of Nrf2 Signaling Pathway.
    J Ocul Pharmacol Ther. 2024 Oct 25. doi: 10.1089/jop.2024.0064.
    >> Share

  66. DIBAS A, Batabyal S, Kim S, Carlson M, et al
    Efficacy of Intravitreal Multi-Characteristic Opsin (MCO-010) Optogenetic Gene Therapy in a Mouse Model of Leber Congenital Amaurosis.
    J Ocul Pharmacol Ther. 2024 Oct 23. doi: 10.1089/jop.2024.0084.
    >> Share

  67. BOUHAJIB M, Tayab Z, Di Marco C, Suh DD, et al
    Clinical Pharmacokinetics of Atropine Administered Ocularly Using an Ultrasensitive Bioanalytical Assay.
    J Ocul Pharmacol Ther. 2024 Oct 4. doi: 10.1089/jop.2024.0113.
    >> Share

  68. SULTAN A, Harris DL, Lam P, Whitcomb J, et al
    The Optejet Technology Minimizes Preservative-Mediated Cytotoxicity of Conjunctival Epithelial Cells Treated with Latanoprost In Vitro.
    J Ocul Pharmacol Ther. 2024 Oct 2. doi: 10.1089/jop.2024.0085.
    >> Share

  69. HILL M, Andrews-Pfannkoch C, Atherton E, Knudsen T, et al
    Detection of Residual iPSCs Following Differentiation of iPSC-Derived Retinal Pigment Epithelial Cells.
    J Ocul Pharmacol Ther. 2024 Oct 2. doi: 10.1089/jop.2024.0130.
    >> Share

  70. MATSUMOTO R, Obata S, Kakinoki M, Sawada O, et al
    Duration of Vascular Endothelial Growth Factor Suppression after Intravitreal Injection of Faricimab in Macaque Eyes.
    J Ocul Pharmacol Ther. 2024 Oct 2. doi: 10.1089/jop.2024.0138.
    >> Share

    September 2024
  71. JUAN HY, Sheu SJ, Hwang DK
    Review of Janus Kinase Inhibitors as Therapies for Noninfectious Uveitis.
    J Ocul Pharmacol Ther. 2024 Sep 24. doi: 10.1089/jop.2024.0100.
    >> Share

  72. LUHAR M, Viradiya R, Panjabi S, Patel G, et al
    Nanotechnology in Ocular Drug Delivery: The Potential of Polymeric Micelles as a Drug Delivery Vehicle.
    J Ocul Pharmacol Ther. 2024 Sep 12. doi: 10.1089/jop.2024.0060.
    >> Share

  73. TSENG KA
    Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Journal of Ocular Pharmacology and Therapeutics.
    J Ocul Pharmacol Ther. 2024;40:407.
    >> Share

  74. FUKUDA M, Kiyoi T, Takeda S, Sasaki Y, et al
    Preventative Effect of Topical Rebamipide Against Corneal Epithelium Disorders Caused by Diclofenac Sodium.
    J Ocul Pharmacol Ther. 2024;40:428-434.
    >> Share

  75. NOVACK GD
    Eyes on New Product Development.
    J Ocul Pharmacol Ther. 2024;40:408-409.
    >> Share

  76. ZHAO Y, Zhang X, Zhou X, Chen B, et al
    IL-22/IL-22RA1 Promotes Human Tenon's Capsule Fibroblasts Proliferation and Regulates Fibrosis Through STAT3 Signaling Pathway.
    J Ocul Pharmacol Ther. 2024;40:435-444.
    >> Share

    August 2024
  77. GAO AY, Whaley MG, Saraf N, Bakri SJ, et al
    Survey of Dopamine Receptor D2 Antagonists as Retinal Antifibrotics.
    J Ocul Pharmacol Ther. 2024 Aug 29. doi: 10.1089/jop.2024.0006.
    >> Share

  78. DURRANI AF, Momenaei B, Soni V, Tennant M, et al
    Long-Term Stability, Sterility, And Cost-Effectiveness of 0.05% Chlorhexidine Gluconate as Antisepsis for Intravitreal Injection.
    J Ocul Pharmacol Ther. 2024 Aug 22. doi: 10.1089/jop.2024.0071.
    >> Share

  79. BACHARACH J, McLaurin EB, Silverstein S, Amrane M, et al
    Efficacy and Safety of a Preservative-Free Latanoprost Cationic Emulsion in Patients with Open-Angle Glaucoma and Concurrent Ocular Surface Disease: A Randomized Phase 2 Study.
    J Ocul Pharmacol Ther. 2024 Aug 16. doi: 10.1089/jop.2024.0029.
    >> Share

  80. CREAN CS, Yeu E, Maiti S, Neervannan S, et al
    Ocular and Systemic Pharmacokinetics of Lotilaner Ophthalmic Solution, 0.25%, Following a Single Dose or Repeated Doses in Dutch-Belted Rabbits.
    J Ocul Pharmacol Ther. 2024 Aug 16. doi: 10.1089/jop.2024.0074.
    >> Share

    July 2024
  81. WON J, Kang J, Kang W
    Comparative Ocular Pharmacokinetics of Dexamethasone Implants in Rabbits.
    J Ocul Pharmacol Ther. 2024 Jul 24. doi: 10.1089/jop.2024.0052.
    >> Share

  82. HAMEED SS, Bodi NE, Miller RC, Sharma TP, et al
    Neuritin 1 Drives Therapeutic Preservation of Retinal Ganglion Cells in an Ex Vivo Human Glaucoma Model.
    J Ocul Pharmacol Ther. 2024 Jul 12. doi: 10.1089/jop.2024.0041.
    >> Share

  83. ZEMITIS A, Vanags J, Fan J, Klavins K, et al
    Metabolomic Disparities in Intraocular Fluid Across Varied Stages of Cataract Progression: Implications for the Analysis of Cataract Development.
    J Ocul Pharmacol Ther. 2024 Jul 8. doi: 10.1089/jop.2024.0067.
    >> Share

  84. CHAUVIER J, Trone MC, Gain P, Ollier E, et al
    Corneal Toxicity in Patients Treated by BELANTAMAB MAFODOTIN: How to Improve and Facilitate Patients Follow-Up Using Refractive Shift?
    J Ocul Pharmacol Ther. 2024 Jul 8. doi: 10.1089/jop.2024.0023.
    >> Share

  85. KASHIKAR R, Senapati S, Dudhipala N, Basu SK, et al
    Ophthalmic Nanoemulsion Fingolimod Formulation for Topical Application.
    J Ocul Pharmacol Ther. 2024 Jul 8. doi: 10.1089/jop.2024.0055.
    >> Share

  86. DOLAN K, Liao SM, Crowley M, Xiang C, et al
    Complement Factor B Inhibition or Deletion Is Not Sufficient to Prevent Neurodegeneration in a Murine Model of Glaucoma.
    J Ocul Pharmacol Ther. 2024 Jul 8. doi: 10.1089/jop.2024.0046.
    >> Share

  87. ZOR KR, Yilmaz U, Bozkurt SB
    Coenzyme Q10 and Vitamin E Regulate the Bioactivity of Human Corneal Fibroblast Cells.
    J Ocul Pharmacol Ther. 2024 Jul 8. doi: 10.1089/jop.2024.0050.
    >> Share

  88. MENG C, Wei Q, Gu C, He S, et al
    Prevalence and Risk Factors of Ocular Demodex at Ultra-High Altitude and Sea Level: A Cross-Sectional Study of Shigatse and Shanghai.
    J Ocul Pharmacol Ther. 2024 Jul 4. doi: 10.1089/jop.2024.0038.
    >> Share

  89. PAGNACCO C, Tosi R, Dalsaso J, Fraccaroli S, et al
    A Prospective, Randomized, Controlled Clinical Investigation Comparing the Efficacy and Safety of Sodium Hyaluronate-Based Ophthalmical Viscosurgical Devices FIDIAL PLUS and IAL((R))-F in Cataract Surgery.
    J Ocul Pharmacol Ther. 2024 Jul 1. doi: 10.1089/jop.2024.0044.
    >> Share

  90. YAO Q, Wu H, Ren H, Cao J, et al
    Inhibition of Experimental Corneal Neovascularization by the Tight Junction Protein ZO-1.
    J Ocul Pharmacol Ther. 2024;40:379-388.
    >> Share

  91. NOVACK GD
    Eyes on New Product Development.
    J Ocul Pharmacol Ther. 2024;40:325-326.
    >> Share

  92. MICHAEL E, Singh V
    Diagnostic Uses of Common Eye Drops.
    J Ocul Pharmacol Ther. 2024;40:327-331.
    >> Share

    June 2024
  93. KLEINMAN D, Iqbal S, Ghosh AK, Ogle SD, et al
    PLL-g-PEG Polymer Inhibits Antibody-Drug Conjugate Uptake into Human Corneal Epithelial Cells In Vitro.
    J Ocul Pharmacol Ther. 2024 Jun 27. doi: 10.1089/jop.2024.0019.
    >> Share

  94. VARDAR C, George-Weinstein M, Getts R, Byrne ME, et al
    Evaluation of Dose-Response Relationship in Novel Extended Release of Targeted Nucleic Acid Nanocarriers to Treat Secondary Cataracts.
    J Ocul Pharmacol Ther. 2024 Jun 20. doi: 10.1089/jop.2024.0024.
    >> Share

  95. LIU L, Wang S, Blanco T, Ge H, et al
    Neurokinin-1 Receptor Antagonism Reduces Nonallergic Ocular Redness in a Rabbit Model.
    J Ocul Pharmacol Ther. 2024 Jun 3. doi: 10.1089/jop.2024.0003.
    >> Share

  96. LEE SS, Nagar S, Rajagopalan L, Orilla W, et al
    Using a Novel, Subconjunctival, Sustained-Release Mitomycin C Formulation in a Rabbit Model of Filtration Surgery with Gel Stent Implantation.
    J Ocul Pharmacol Ther. 2024;40:297-308.
    >> Share

  97. NOVACK GD
    Eyes on New Product Development.
    J Ocul Pharmacol Ther. 2024;40:259-260.
    >> Share

    May 2024
  98. ANDERSON SG, Meyer D, Decloedt EH
    The Ocular Penetration and Intraocular Pressure Lowering Effect of Topical Acetaminophen in the New Zealand White Rabbit.
    J Ocul Pharmacol Ther. 2024 May 27. doi: 10.1089/jop.2024.0020.
    >> Share

  99. NOVACK GD
    Eyes on New Product Development.
    J Ocul Pharmacol Ther. 2024;40:203.
    >> Share

    April 2024
  100. GUO M, Liu T, Miao Y, Pan X, et al
    Role of NADPH Oxidase 4 on Dry Eye Syndrome in Mice.
    J Ocul Pharmacol Ther. 2024 Apr 26. doi: 10.1089/jop.2024.0002.
    >> Share

  101. NERI P, Perez Y, Agarwal A, Pichi F, et al
    Unraveling the Complexities of Severe Acute Respiratory Syndrome Coronavirus 2: A Comprehensive Ophthalmic and Systemic Perspective.
    J Ocul Pharmacol Ther. 2024 Apr 25. doi: 10.1089/jop.2024.0037.
    >> Share

  102. BISEN AC, Srivastava S, Mishra A, Sanap SN, et al
    Pharmaceutical Emulsions: A Viable Approach for Ocular Drug Delivery.
    J Ocul Pharmacol Ther. 2024 Apr 23. doi: 10.1089/jop.2023.0166.
    >> Share

  103. ANAM A, Liu C, Tong L, Liu YC, et al
    Blood-Derived Eye Drops for the Treatment of Corneal Neuropathic Pain.
    J Ocul Pharmacol Ther. 2024 Apr 22. doi: 10.1089/jop.2023.0155.
    >> Share

  104. GONZALEZ VH, Uram M, Schupp A, Widmann M, et al
    AG-920 (Articaine) Ophthalmic Solution: A Masked, Active-Controlled Evaluation of Its Local Anesthetic Efficacy and Safety in Pediatric Patients.
    J Ocul Pharmacol Ther. 2024 Apr 22. doi: 10.1089/jop.2023.0187.
    >> Share

  105. TRAN HDM, Ha TTX, Tran YH, Coroneo M, et al
    Impact of Various Concentrations of Low-Dose Atropine on Pupillary Diameter and Accommodative Amplitude in Children with Myopia.
    J Ocul Pharmacol Ther. 2024 Apr 15. doi: 10.1089/jop.2023.0173.
    >> Share

  106. HUSAIN S, Obert E, Singh S, Schnabolk G, et al
    Inhibition of HDAC1 and 3 in the Presence of Systemic Inflammation Reduces Retinal Degeneration in a Model of Dry Age-Related Macular Degeneration.
    J Ocul Pharmacol Ther. 2024 Apr 12. doi: 10.1089/jop.2023.0163.
    >> Share

  107. YADAV KS, Bisen AC, Ishteyaque S, Sharma I, et al
    Solanum nigrum Toxicity and Its Neuroprotective Effect Against Retinal Ganglion Cell Death Through Modulation of Extracellular Matrix in a Glaucoma Rat Model.
    J Ocul Pharmacol Ther. 2024 Apr 11. doi: 10.1089/jop.2023.0089.
    >> Share

  108. MISHRA A, Agrawal M, Tripathi A, Bhirud A, et al
    A Comparative Study on Efficacy of Intraocular Pressure Lowering of Two Fixed-Dose Antiglaucoma Drug Combination Brinzolamide-Brimonidine Versus Latanoprost-Timolol in Primary Open-Angle Glaucoma and Ocular Hypertension.
    J Ocul Pharmacol Ther. 2024 Apr 10. doi: 10.1089/jop.2023.0186.
    >> Share

  109. DIAS PB, Rodrigues Parchen MDA, Wasilewski D
    Comparison of Proparacaine, Tetracaine, and Oxybuprocaine in Corneal Sensitivity Measurement.
    J Ocul Pharmacol Ther. 2024 Apr 8. doi: 10.1089/jop.2023.0148.
    >> Share

  110. GARWEG JG, Pietzuch M, Mantel I, Ambresin A, et al
    Response to the Letter to the Editor by Michael Colucciello, MD, FASRS, Entitled "Steroid/Anti-VEGF Combination Therapy for Neovascular AMD".
    J Ocul Pharmacol Ther. 2024;40:199-200.
    >> Share

  111. NOVACK GD
    Eyes on New Product Development.
    J Ocul Pharmacol Ther. 2024;40:158-159.
    >> Share

  112. WATANABE M, Sato T, Umetsu A, Nishikiori N, et al
    Differential Effects of Benzalkonium Chloride on Human Trabecular Meshwork Cells Not Treated or Treated with Transforming Growth Factor-beta2 or Dexamethasone.
    J Ocul Pharmacol Ther. 2024;40:189-196.
    >> Share

  113. GAO J, Wang Y, Han R, Li J, et al
    Elevated KDM4D Expression in Pterygium: Impact and Potential Inhibition by Lycium Barbarum Polysaccharide.
    J Ocul Pharmacol Ther. 2024;40:181-188.
    >> Share

    March 2024
  114. CHENG Y, Liu G
    Evaluation of the Treatment Effects of Conditioned Medium from Human Orbital Adipose-Derived Stem Cells in a Corneal Alkali Burn Rabbit Model.
    J Ocul Pharmacol Ther. 2024 Mar 28. doi: 10.1089/jop.2023.0154.
    >> Share

  115. CID-BERTOMEU P, Vilaltella M, Martinez M, Mir M, et al
    Topical Insulin for Ocular Surface Disease.
    J Ocul Pharmacol Ther. 2024 Mar 22. doi: 10.1089/jop.2024.0016.
    >> Share

  116. MURAKAMI Y, Imaizumi T, Hashizume K, Tezuka Y, et al
    Inhibition of Connective Tissue Growth Factor Expression in Adult Retinal Pigment Epithelial-19 Cells by Blocking Yes-Associated Protein/Transcriptional Coactivator with PDZ-Binding Motif Activity.
    J Ocul Pharmacol Ther. 2024 Mar 22. doi: 10.1089/jop.2023.0141.
    >> Share

  117. YILMAZ OF, Sarmis A
    Relationship Between Conjunctival Corynebacterium and 5% Sheep Blood Agar.
    J Ocul Pharmacol Ther. 2024 Mar 6. doi: 10.1089/jop.2024.0010.
    >> Share

  118. COLUCCIELLO M
    Steroid/AntiVascular Endothelial Growth Factor Combination Therapy for Neovascular Age-Related Macular Degeneration.
    J Ocul Pharmacol Ther. 2024 Mar 6. doi: 10.1089/jop.2024.0013.
    >> Share

  119. LEE JH, Kim JH
    Impact of Prolonged Persisting Subretinal Fluid on the Outcome of Aflibercept Treatment in Neovascular Age-Related Macular Degeneration.
    J Ocul Pharmacol Ther. 2024;40:136-143.
    >> Share

  120. NOVACK GD
    Eyes on New Product Development.
    J Ocul Pharmacol Ther. 2024;40:109-110.
    >> Share

  121. FIGUS M, Giansanti F, Villani E, Alio JL, et al
    Chloroprocaine 3% Gel as a Novel Ocular Topical Anesthetic: Results from a Multicenter, Randomized Clinical Trial in Patients Undergoing Cataract Surgery.
    J Ocul Pharmacol Ther. 2024;40:117-125.
    >> Share

    February 2024
  122. RUAN M, Wang R, He Y
    Novel Drug Delivery Systems for the Management of Fungal Keratitis.
    J Ocul Pharmacol Ther. 2024 Feb 23. doi: 10.1089/jop.2023.0161.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016